JP7646137B2 - 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品 - Google Patents

精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品 Download PDF

Info

Publication number
JP7646137B2
JP7646137B2 JP2023572498A JP2023572498A JP7646137B2 JP 7646137 B2 JP7646137 B2 JP 7646137B2 JP 2023572498 A JP2023572498 A JP 2023572498A JP 2023572498 A JP2023572498 A JP 2023572498A JP 7646137 B2 JP7646137 B2 JP 7646137B2
Authority
JP
Japan
Prior art keywords
inflammatory
hot water
water extract
extract
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023572498A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023132372A5 (https=
JPWO2023132372A1 (https=
Inventor
義則 保苅
亜矢 関根
由彦 柿沼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Medical School Foundation
Maruhachi Muramatsu Inc
Original Assignee
Nippon Medical School Foundation
Maruhachi Muramatsu Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Medical School Foundation, Maruhachi Muramatsu Inc filed Critical Nippon Medical School Foundation
Publication of JPWO2023132372A1 publication Critical patent/JPWO2023132372A1/ja
Publication of JPWO2023132372A5 publication Critical patent/JPWO2023132372A5/ja
Priority to JP2025026309A priority Critical patent/JP2025081566A/ja
Application granted granted Critical
Publication of JP7646137B2 publication Critical patent/JP7646137B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2023572498A 2022-01-07 2023-01-10 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品 Active JP7646137B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025026309A JP2025081566A (ja) 2022-01-07 2025-02-21 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263266531P 2022-01-07 2022-01-07
US63/266,531 2022-01-07
PCT/JP2023/000272 WO2023132372A1 (ja) 2022-01-07 2023-01-10 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025026309A Division JP2025081566A (ja) 2022-01-07 2025-02-21 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Publications (3)

Publication Number Publication Date
JPWO2023132372A1 JPWO2023132372A1 (https=) 2023-07-13
JPWO2023132372A5 JPWO2023132372A5 (https=) 2024-08-09
JP7646137B2 true JP7646137B2 (ja) 2025-03-17

Family

ID=87073805

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023572498A Active JP7646137B2 (ja) 2022-01-07 2023-01-10 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品
JP2025026309A Pending JP2025081566A (ja) 2022-01-07 2025-02-21 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025026309A Pending JP2025081566A (ja) 2022-01-07 2025-02-21 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Country Status (3)

Country Link
US (1) US20250057890A1 (https=)
JP (2) JP7646137B2 (https=)
WO (1) WO2023132372A1 (https=)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000132A1 (fr) 1992-06-24 1994-01-06 Pierre Fabre Medicament Utilisation de la guanosine, de ses precurseurs et ses derives pour la fabrication de medicaments destines a traiter les deficits fonctionnels cerebraux
JP2004525136A (ja) 2001-03-26 2004-08-19 イノテック ファーマシューティカルズ コーポレーション イノシン化合物及び炎症性疾患もしくは再灌流疾患の治療又は予防のためのその使用
WO2017068805A1 (ja) 2015-10-22 2017-04-27 ライオン株式会社 唾液分泌促進剤、これを含有する口腔用組成物及び飲料用組成物
JP2018080135A (ja) 2016-11-17 2018-05-24 株式会社スタージェン パーキンソン症状改善用医薬
JP2018118914A (ja) 2017-01-24 2018-08-02 株式会社スタージェン 神経変性疾患の改善用医薬

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000132A1 (fr) 1992-06-24 1994-01-06 Pierre Fabre Medicament Utilisation de la guanosine, de ses precurseurs et ses derives pour la fabrication de medicaments destines a traiter les deficits fonctionnels cerebraux
JP2004525136A (ja) 2001-03-26 2004-08-19 イノテック ファーマシューティカルズ コーポレーション イノシン化合物及び炎症性疾患もしくは再灌流疾患の治療又は予防のためのその使用
WO2017068805A1 (ja) 2015-10-22 2017-04-27 ライオン株式会社 唾液分泌促進剤、これを含有する口腔用組成物及び飲料用組成物
JP2018080135A (ja) 2016-11-17 2018-05-24 株式会社スタージェン パーキンソン症状改善用医薬
JP2018118914A (ja) 2017-01-24 2018-08-02 株式会社スタージェン 神経変性疾患の改善用医薬

Also Published As

Publication number Publication date
JP2025081566A (ja) 2025-05-27
WO2023132372A1 (ja) 2023-07-13
US20250057890A1 (en) 2025-02-20
JPWO2023132372A1 (https=) 2023-07-13

Similar Documents

Publication Publication Date Title
Miyanohara et al. TRPM2 channel aggravates CNS inflammation and cognitive impairment via activation of microglia in chronic cerebral hypoperfusion
Li et al. Sedative and hypnotic effects of Schisandrin B through increasing GABA/Glu ratio and upregulating the expression of GABAA in mice and rats
Yamamoto et al. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation
Pu et al. Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury
Palmeri et al. Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory
Salvati et al. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain
US8481087B2 (en) Withania somnifera plant extract and method of preparation thereof
Morley et al. Alzheimer’s disease through the eye of a mouse: acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize
JP2012529487A (ja) 脳疾患及び状態の予防及び治療のための組成物及び方法
Yang et al. Berberine attenuates depression-like behavior by modulating the hippocampal NLRP3 ubiquitination signaling pathway through Trim65
Yuan et al. Neuroprotective effects of nitidine against traumatic CNS injury via inhibiting microglia activation
Sui et al. Protective and therapeutic role of Bilobalide in cuprizone-induced demyelination
JP6774664B2 (ja) 退行性脳疾患の予防又は治療効果を有するアガトバキュラム属菌株及びその用途
CN102959400A (zh) 受试物质的判定或评价方法
Lin et al. Neurogranin as an important regulator in swimming training to improve the spatial memory dysfunction of mice with chronic cerebral hypoperfusion
Shi et al. Sleep deprivation alleviates depression-like behaviors in mice via inhibiting immune and inflammatory pathways and improving neuroplasticity
JP7646137B2 (ja) 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品
KR20200064430A (ko) 수면장애에 의해 유발되는 학습 및 기억 장애 치료용 약학적 조성물
CN103877144B (zh) 花生衣活性组分的应用及包含该花生衣活性组分的组合物
KR102129006B1 (ko) 수면장애에 의해 유발되는 학습 및 기억 장애 치료용 약학적 조성물
CN115990187B (zh) 一种用于改善阿尔茨海默病的中药提取物及其应用
JP2012524097A (ja) プロａｄａｍ１０セクレターゼ及び／又はベータセクレターゼレベルの減少方法
Wang et al. Spike RBD drives sustained Parkinson’s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation
CA3255097A1 (en) Apelin receptor modulators for the treatment of a disorder or disease associated with blood-brain barrier permeability
CN116270743A (zh) 脂质运载蛋白型前列腺素d2合成酶产生促进剂

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240617

A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20240617

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240617

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20240617

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241029

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250204

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250221

R150 Certificate of patent or registration of utility model

Ref document number: 7646137

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150